Health
Eyepoint Treatment Fails to Impress in Wet AMD Study
Eyepoint's experimental treatment for wet age-related macular degeneration (AMD) failed to show significant improvement over standard treatments. The company remains optimistic about future prospects.
Coverage timeline — 1 article
STAT News
Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.
2026-08-17 18:45 UTC